BLOG

September 2026

Webster Psychiatric Center Celebrates Two 2026 Awards for Excellence in Psychiatric Care

Webster Psychiatric Center is proud to announce that we have been recognized with two distinguished honors in 2026: the Elite Customer Satisfaction Award and the Breakthrough Business Award for Psychiatric Medication Management in Burlington, Massachusetts.

These recognitions represent an exciting milestone for our practice and reflect our continued commitment to providing accessible, responsive, and compassionate psychiatric care to the individuals and families we serve.

2026 Elite Customer Satisfaction Award

Receiving the 2026 Elite Customer Satisfaction Award is especially meaningful to our team because the patient experience is at the center of everything we do.

Seeking psychiatric care can sometimes feel overwhelming. At Webster Psychiatric Center, we work to make the process as comfortable and straightforward as possible—from the first inquiry and initial psychiatric evaluation through ongoing medication management and follow-up care.

Our goal is to provide patients with a practice where they feel heard, respected, and supported while receiving professional psychiatric care tailored to their individual needs.

This recognition reinforces our commitment to maintaining a high standard of service and continually improving the experience of our patients.

2026 Breakthrough Business Award

Webster Psychiatric Center is also honored to receive the 2026 Breakthrough Business Award for Psychiatric Medication Management in Burlington, Massachusetts.

This award represents another important milestone in the continued growth of our practice.

Webster Psychiatric Center provides psychiatric evaluations and ongoing medication management, with care delivered by experienced psychiatric mental health nurse practitioners. Our providers work collaboratively with patients to develop individualized treatment plans and provide continued monitoring and support.

As our practice has grown, we have remained focused on maintaining the personalized approach that has been part of Webster Psychiatric Center from the beginning.

Growing While Keeping Patients First

Our growth would not be possible without the trust of our patients, families, referral partners, therapists, healthcare professionals, and community organizations.

Every referral, recommendation, review, and patient who chooses Webster Psychiatric Center has contributed to what we have built.

While we are proud to receive these awards, they also serve as motivation to continue improving. We remain committed to expanding access to quality psychiatric services while preserving the responsive and personal experience our patients expect.

Psychiatric Medication Management in Burlington, Massachusetts

Webster Psychiatric Center is based in Burlington, Massachusetts, and provides psychiatric evaluation and medication management services through telehealth and available in-person care.

Our psychiatric services include:

Comprehensive psychiatric evaluations
Psychiatric medication management
Ongoing medication monitoring and follow-up
Individualized treatment planning
Telehealth psychiatric appointments
Care for children, adolescents, and adults, depending on provider
Coordination with therapists and other healthcare professionals when appropriate

Our providers are licensed across multiple states, allowing Webster Psychiatric Center to serve patients beyond the Burlington and Greater Boston communities through telehealth where permitted.

Thank You for Being Part of Our Growth

Being recognized with both the 2026 Elite Customer Satisfaction Award and the 2026 Breakthrough Business Award for Psychiatric Medication Management in Burlington, Massachusetts is something our entire team is proud to celebrate.

Most importantly, we want to thank our patients and professional partners for trusting Webster Psychiatric Center with their care and referrals.

These awards recognize what we have accomplished so far—but we believe we are only getting started.

Webster Psychiatric Center
1500 District Avenue
Burlington, MA 01803
Phone: 978-404-5323

Compassionate psychiatric care. Personalized treatment. Continued commitment to the people and communities we serve.

CRI

November 2025

Association_of_Migraine_Disorders_Logo (1).jpg

Theresa Webster of Webster Psychiatric Center has joined The Association of Mirgarine Disorders, an organization passionate about migraine, patient care, physician education, and research. Its members come from a variety of specialty areas, including otolaryngology, neurology, and neurotology. The organization’s three main areas of focus are research, education, and awareness of migraine disorders. Theresa brings decades of brain-injury and cluster-headache expertise to the dedicated team.

Association of Migraine Disorders

Bio:
Theresa Webster, MSN, PMHNP-BC, is an ANCC board-certified psychiatric–mental health nurse practitioner with more than fifteen years of experience providing comprehensive mental health care. She is the founder of Webster Psychiatric Center and currently practices in private practice, offering medication management and therapeutic support to children, adolescents, and adults. While physically based in Massachusetts, she is licensed to provide care in ten states, including MA, NH, NJ, NY, FL, CT, PA, WA, OR, and ME.

A graduate of the Massachusetts College of Pharmacy and Health Sciences, Theresa brings a broad clinical background to her work with individuals facing depression, anxiety disorders, ADHD, and trauma-related conditions. Her clinical style centers on truly understanding each patient’s lived experience and creating personalized treatment plans that align with their goals, strengths, and daily realities.

Theresa has a particular interest in the intersection between mental health and chronic pain. She is deeply invested in supporting individuals navigating the complexities of migraine, chronic pain syndromes, and the profound disruption that cluster headaches can cause. She approaches care with an emphasis on validation, education, and evidence-based strategies aimed at improving functioning and overall well-being.

Theresa is dedicated to empowering patients to better understand their symptoms, build effective coping strategies, and move toward meaningful, sustained improvement in their quality of life.

Learn more!

Click Above!

September 2025

Webster Psychiatric Center Joins the ClusterBusters Annual Conference

This September, Webster Psychiatric Center had the privilege of traveling to Dallas, Texas, to take part in the annual ClusterBusters Conference. The gathering welcomed more than 200 attendees, including physicians, nurse practitioners, patients, caregivers, and pain management specialists, all with one shared goal: improving the understanding and treatment of cluster headaches.

What Are Cluster Headaches?

Cluster headaches (CH) are a neurological condition marked by sudden, severe headaches, almost always affecting one side of the head and often concentrated around the eye. They fall under the category of primary headache disorders, meaning they are not caused by another illness or condition.

Sometimes referred to as “suicide headaches”, cluster headaches are known for their extraordinary intensity and the toll they take on those who suffer from them. Unlike migraines, which often drive patients to rest quietly in darkened rooms, cluster headache attacks can cause individuals to pace, sweat, cry out, and even experience suicidal thoughts as a desperate attempt to escape the pain—considered by many to be among the most severe known to medicine.

Early recognition and appropriate treatment are essential. Research shows that around one-third of patients initially receive their diagnosis from primary care physicians. This highlights the urgent need for general practitioners to be trained to identify the disorder and create effective treatment plans. Proper intervention can lead to faster relief, less disability, and improved quality of life.

Mental Health and Cluster Headaches

The impact of cluster headaches extends far beyond physical pain. Many patients struggle with anxiety, depression, and feelings of isolation due to the unpredictable and debilitating nature of the disorder. The relentless cycle of attacks can make it difficult to maintain work, relationships, or daily routines, often leaving patients feeling misunderstood or unsupported.

The nickname “suicide headache” reflects not only the unbearable pain but also the mental health crisis it can trigger. Studies and patient reports show that suicidal thoughts are not uncommon among those living with CH. Addressing mental health alongside medical treatment is therefore critical.

At Webster Psychiatric Center, we emphasize a holistic approach—recognizing that effective care must include both medical management of the headaches and psychological support. Interventions such as counseling, support groups, and psychiatric care can reduce feelings of despair, help patients build coping strategies, and foster resilience. Mental health care is not optional; it is an essential part of treating cluster headache patients.

ClusterBusters: Driving Research and Advocacy

ClusterBusters, Inc. was established in 2002 by Robert Wold, who continues to lead the organization as Executive Director. From the beginning, the nonprofit’s mission has been to advocate for patients and partner with research institutions to develop new therapies.

One of their earliest projects focused on the potential use of psilocybin mushrooms for treating cluster headaches. Early collaborations with Harvard researchers in the 2000s provided promising evidence that psychedelic compounds could help reduce the frequency and severity of attacks. In some cases, patients living with chronic CH were able to transition to episodic patterns, gaining months or even years of pain-free time.

Over the years, ClusterBusters has broadened its research efforts, working alongside Yale University, Hannover Medical School in Germany, the U.S. Department of Veterans Affairs, and Children’s Hospital, among others. These partnerships continue to advance knowledge of cluster headaches while exploring innovative strategies for patient care.

Looking Ahead with Hope

Attending the Dallas conference gave our team the chance to connect directly with leading experts, advocates, and patients who are equally dedicated to progress in cluster headache research and treatment. It reinforced our commitment at Webster Psychiatric Center to advancing awareness, supporting innovative science, and advocating for individuals and families affected by this devastating condition.

Though cluster headaches remain one of the most excruciating medical disorders, the growing body of research, collaborative advocacy, and patient-driven initiatives like those led by ClusterBusters offer hope for more effective treatments—and brighter futures—for those who live with CH.